Poly(ADP-ribose): a signaling molecule in different paradigms of cell death.
about
Trial watch - inhibiting PARP enzymes for anticancer therapyEnhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitorsCell death and autophagy in tuberculosisBardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.Wnt/β-catenin signaling reduces Bacillus Calmette-Guerin-induced macrophage necrosis through a ROS -mediated PARP/AIF-dependent pathway.Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation.Oleanolic acid induces mitochondrial-dependent apoptosis and G0/G1 phase arrest in gallbladder cancer cells.p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expressionMolecular features of the cytotoxicity of an NHE inhibitor: Evidence of mitochondrial alterations, ROS overproduction and DNA damage.Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.PARP-1 inhibition influences the oxidative stress response of the human lens.Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to PaclitaxelCTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer.Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP.AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration.The rise and fall of poly(ADP-ribose): An enzymatic perspective.Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions.Mitochondrial poly(ADP-ribose) polymerase: The Wizard of Oz at work.Generation of small molecules to interfere with regulated necrosis.Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.The Promise of Proteomics for the Study of ADP-RibosylationNatural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.Effects of poly (ADP-ribose) polymerase-1 (PARP-1) inhibition on sulfur mustard-induced cutaneous injuries in vitro and in vivo.XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosisNuclear localization of the caspase-3-cleaved form of p73 in anoikis.Oxidative Stress-Related Parthanatos of Circulating Mononuclear Leukocytes in Heart Failure.CREBBP and p300 lysine acetyl transferases in the DNA damage response.Proteomic Profiling Reveals the Induction of UPR in Addition to DNA Damage Response in HeLa Cells Treated With the Thiazolo[5,4-b]Quinoline Derivative D3ClP.Advances in the use of PARP inhibitor therapy for breast cancerTankyrases maintain homeostasis of intestinal epithelium by preventing cell death
P2860
Q26745673-2BE62D4E-C553-466D-8960-195F70590FA4Q26768267-A547E71D-6F20-4DE0-BD80-B01E20128A39Q28387214-71875941-6397-409D-8A70-BB0572719109Q35115295-EBA9969B-41C0-47E6-B395-1FA3A8CAFBEEQ35382133-518E94B0-CF82-4C84-90D0-1F9DDD8AFDA2Q35586755-B4C47844-1355-4DE6-8143-1329D72F986DQ35755011-5C82D6C1-8179-4B14-B3B0-7FD114C062A5Q35885207-21231147-77F9-4B33-BCFD-63790F7BBEF8Q36020900-8EBDCA4C-D952-43D0-A51B-896CB252311FQ36183468-92D45742-D901-4CB9-904F-A90B5C3FA6C1Q36199894-6B034578-4C3C-466A-9811-C3ED5321D9E8Q36703885-F6BD3DFE-F2E9-42BC-BC4D-3D1C9113DF04Q37075249-4B21A23E-7944-414E-902C-2842819F4706Q37173597-341EA3A3-599D-493A-A468-FC1305B058F8Q37718693-E9CCA5D0-6C37-4F02-963E-3EFA6DE4A6A1Q37744863-C118A59B-FD83-42BA-BDD7-A315A386085AQ38473760-844E622D-3867-4C39-972C-8A0F1A99188CQ38740969-E0EBB7A5-6389-4082-9E57-F8D4F1A860B7Q38768778-1A06AD73-8649-470F-B968-21DDDF099982Q38799144-AFAB4379-1610-4C33-9BE2-2019EAEAB87DQ38876257-6A496FAF-78E5-4C67-9029-BC5E9204B346Q38993857-95AE805C-37B3-4943-B11A-924125AF654FQ39214221-5F3C335C-2ADF-4848-BD52-73E868C74CCCQ40127272-BC524146-FE17-44BA-8F09-48733C2C7E4BQ41279921-EC67D8B4-8476-4C8E-9780-C1DA77F2659DQ42593996-63C478FD-30F5-4707-BBF4-DF46A200E8D1Q47283225-AF986F61-3837-43AA-AD9C-766A57927957Q47369126-5E215553-52EE-46BF-9B86-7B8D535339E7Q51450173-2D1AC52D-B670-4A30-ABCB-B952A360D521Q57108063-A7F1AA15-3439-4B76-9ACE-2055337E9E4FQ59127592-995412D2-F567-4F6C-8BD3-C2CC7106C8B0
P2860
Poly(ADP-ribose): a signaling molecule in different paradigms of cell death.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Poly(ADP-ribose): a signaling molecule in different paradigms of cell death.
@en
type
label
Poly(ADP-ribose): a signaling molecule in different paradigms of cell death.
@en
prefLabel
Poly(ADP-ribose): a signaling molecule in different paradigms of cell death.
@en
P1476
Poly(ADP-ribose): a signaling molecule in different paradigms of cell death.
@en
P2093
Francesca Aredia
P304
P356
10.1016/J.BCP.2014.06.021
P407
P577
2014-06-26T00:00:00Z